Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Cash Flows From Operating Activities | ||||
| Net Income | 5,901 | 9,490 | N/A | N/A |
| Depreciation Amortization | 4,489 | 3,370 | N/A | N/A |
| Income taxes - deferred | -771 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -172 | N/A | N/A | N/A |
| Other Working Capital | 688 | -3,190 | N/A | N/A |
| Other Operating Activity | 4,824 | 970 | 0 | 0 |
| Operating Cash Flow | $14,959 | $10,640 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -4,902 | -11,180 | N/A | N/A |
| Other Investing Activity | 16 | -510 | 0 | 0 |
| Investing Cash Flow | $-4,886 | $-11,690 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Change In Short Term Borrowing | 2,816 | N/A | N/A | N/A |
| Debt Issued | 10,000 | N/A | N/A | N/A |
| Debt Repayment | -500 | N/A | N/A | N/A |
| Common Stock Issued | 210 | N/A | N/A | N/A |
| Common Stock Repurchased | -23,556 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 1,140 | 0 | 0 |
| Financing Cash Flow | $-11,030 | $1,140 | $N/A | $N/A |
| Exchange Rate Effect | -249 | -90 | N/A | N/A |
| Beginning Cash Position | 2,617 | 2,600 | N/A | N/A |
| End Cash Position | 1,411 | 2,610 | N/A | N/A |
| Net Cash Flow | $-1,206 | $9 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | 14,959 | 10,640 | N/A | N/A |
| Capital Expenditure | -4,927 | N/A | N/A | N/A |
| Free Cash Flow | 10,032 | 10,640 | 0 | 0 |